Stay updated with breaking news from Frier Levitt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In 2024, the Asembia Specialty Pharmacy Summit celebrated 20 years and speakers highlighted the conversations around improving access and affordability taking place at the meeting.
Jonathan E. Levitt, Esq, founding partner of boutique health care law firm Frier Levitt, LLC, discusses a recent class-action lawsuit brought against Johnson & Johnson in which an employee alleged a breach of fiduciary duty regarding her employer-sponsored pharmacy benefits.
This panel at the Community Oncology Alliance conference discussed the impact of PBM response to the end of direct and indirect remuneration (DIR) fees, which has been dramatic cuts to cancer drug reimbursement.
PBMs have used various strategies over the years to squeeze independent pharmacies, and these tactics are on the rise as the federal government takes aim at reigning in the notorious middlemen.
On this episode, Dae Lee, Pharm.D., Esq., CPBS , and Harini Bupathi, Esq, attorneys at Frier Levitt, engage in a thought-provoking conversation on the evolving landscape of pharmacy benefit manager (PBM) audit strategies, regulations, and enforcement.